Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esteban Braggio

Showing results (11-20 of 144) with videos related to

Pageof 15
Sort By:
Current Oncology Reports|August 1, 2013
Genetic factors and pathogenesis of Waldenström's macroglobulinemiaJorge Monge, Esteban Braggio, Stephen M Ansell
Clinical Lymphoma, Myeloma & Leukemia|July 17, 2013
Dissecting karyotypic patterns in non-hyperdiploid multiple myeloma: an overview on the karyotypic evolutionVictor H Jimenez-Zepeda, Esteban Braggio, Rafael Fonseca
Cancer Cell|November 12, 2015
SnapShot: Multiple MyelomaEsteban Braggio, K Martin Kortüm, A Keith Stewart
European Journal of Haematology|June 23, 2011
Chromosome abnormalities defined by conventional cytogenetics in plasma cell leukemia: what have we learned about its biology?Victor H Jimenez-Zepeda, Yvette Neme-Yunes, Esteban Braggio
Clinical Lymphoma, Myeloma & Leukemia|July 27, 2017
Precision Medicine in Myeloma: Challenges in Defining an Actionable ApproachVerónica González-Calle, Niamh Keane, Esteban Braggio, et al.
Revista Medica De Chile|July 23, 2009
[Genetic markers as prognostic factors in multiple myeloma]Guillermo Conte L, Esteban Braggio, Gastón Figueroa, et al.
Haematologica|July 10, 2012
Molecular pathogenesis of Waldenstrom's macroglobulinemiaEsteban Braggio, Casey Philipsborn, Anne Novak, et al.
Thrombosis Research|February 5, 2014
Absence of tissue factor is characteristic of lymphoid malignancies of both T- and B-cell originGabriela Cesarman-Maus, Esteban Braggio, Carmen Lome-Maldonado, et al.
American Journal of Hematology|November 25, 2021
Measles, rubella, and mumps titers post chemotherapy plus autologous stem cell transplant in multiple myeloma patientsMariano Arribas, Greg J Ahmann, Skye Buckner Petty, et al.
Haematologica|May 30, 2013
Hypodiploid multiple myeloma is characterized by more aggressive molecular markers than non-hyperdiploid multiple myelomaScott Van Wier, Esteban Braggio, Angela Baker, et al.
Pageof 15

Showing results (11-20 of 144) with videos related to

Sort By:
Pageof 15
Current Oncology Reports|August 1, 2013
Genetic factors and pathogenesis of Waldenström's macroglobulinemiaJorge Monge, Esteban Braggio, Stephen M Ansell
Clinical Lymphoma, Myeloma & Leukemia|July 17, 2013
Dissecting karyotypic patterns in non-hyperdiploid multiple myeloma: an overview on the karyotypic evolutionVictor H Jimenez-Zepeda, Esteban Braggio, Rafael Fonseca
Cancer Cell|November 12, 2015
SnapShot: Multiple MyelomaEsteban Braggio, K Martin Kortüm, A Keith Stewart
European Journal of Haematology|June 23, 2011
Chromosome abnormalities defined by conventional cytogenetics in plasma cell leukemia: what have we learned about its biology?Victor H Jimenez-Zepeda, Yvette Neme-Yunes, Esteban Braggio
Clinical Lymphoma, Myeloma & Leukemia|July 27, 2017
Precision Medicine in Myeloma: Challenges in Defining an Actionable ApproachVerónica González-Calle, Niamh Keane, Esteban Braggio, et al.
Revista Medica De Chile|July 23, 2009
[Genetic markers as prognostic factors in multiple myeloma]Guillermo Conte L, Esteban Braggio, Gastón Figueroa, et al.
Haematologica|July 10, 2012
Molecular pathogenesis of Waldenstrom's macroglobulinemiaEsteban Braggio, Casey Philipsborn, Anne Novak, et al.
Thrombosis Research|February 5, 2014
Absence of tissue factor is characteristic of lymphoid malignancies of both T- and B-cell originGabriela Cesarman-Maus, Esteban Braggio, Carmen Lome-Maldonado, et al.
American Journal of Hematology|November 25, 2021
Measles, rubella, and mumps titers post chemotherapy plus autologous stem cell transplant in multiple myeloma patientsMariano Arribas, Greg J Ahmann, Skye Buckner Petty, et al.
Haematologica|May 30, 2013
Hypodiploid multiple myeloma is characterized by more aggressive molecular markers than non-hyperdiploid multiple myelomaScott Van Wier, Esteban Braggio, Angela Baker, et al.
Pageof 15